Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Azevedo SX"'
Autor:
Saraiva M; Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de Santo António, Largo Professor Abel Salazar, 4099-001, Porto, Portugal. miguelsaraiva.md@gmail.com., da Inez Correia R; Department of General Surgery, Centro Hospitalar Universitário de Santo António, Largo Professor Abel Salazar, 4099-001, Porto, Portugal., Azevedo SX; Department of Oncology, Centro Hospitalar Universitário de Santo António, Largo Professor Abel Salazar, 4099-001, Porto, Portugal., Brandão JR; Department of Pathological Anatomy, Centro Hospitalar Universitário de Santo António, Largo Professor Abel Salazar, 4099-001, Porto, Portugal., Oliveira JC; Department of Clinical Chemistry, Centro Hospitalar Universitário de Santo António, Largo Professor Abel Salazar, 4099-001, Porto, Portugal., Palma I; Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de Santo António, Largo Professor Abel Salazar, 4099-001, Porto, Portugal.
Publikováno v:
Journal of the Egyptian National Cancer Institute [J Egypt Natl Canc Inst] 2024 Jul 15; Vol. 36 (1), pp. 24. Date of Electronic Publication: 2024 Jul 15.
Autor:
Coelho JQ; Unidade Local de Saúde de Santo António, Porto, Portugal. v.joao.q.coelho@gmail.com., Ramos MJ; Unidade Local de Saúde de Santo António, Porto, Portugal., Ranchor R; Unidade Local de Saúde de Santo António, Porto, Portugal., Pichel R; Unidade Local de Saúde de Santo António, Porto, Portugal., Guerra L; Unidade Local de Saúde de Santo António, Porto, Portugal., Miranda H; Unidade Local de Saúde de Santo António, Porto, Portugal., Simões J; Unidade Local de Saúde de Santo António, Porto, Portugal., Azevedo SX; Unidade Local de Saúde de Santo António, Porto, Portugal., Febra J; Unidade Local de Saúde de Santo António, Porto, Portugal., Araújo A; Unidade Local de Saúde de Santo António, Porto, Portugal.; Oncology Research Unit, UMIB - Unit for Multidisciplinary Research in Biomedicine, ICBAS - School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Jul; Vol. 26 (7), pp. 1549-1560. Date of Electronic Publication: 2024 Feb 08.
Autor:
Coelho JQ; Unidade Local de Saúde de Santo António, 4099-001 Porto, Portugal., Romão R; Unidade Local de Saúde de Santo António, 4099-001 Porto, Portugal., Sousa MJ; Unidade Local de Saúde de Santo António, 4099-001 Porto, Portugal., Azevedo SX; Unidade Local de Saúde de Santo António, 4099-001 Porto, Portugal., Fidalgo P; Unidade Local de Saúde de Santo António, 4099-001 Porto, Portugal., Araújo A; Unidade Local de Saúde de Santo António, 4099-001 Porto, Portugal.; Oncology Research Unit, 4050-346 Porto, Portugal.; UMIB-Unit for Multidisciplinary Research in Biomedicine, 4050-346 Porto, Portugal.; ICBAS-School of Medicine and Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Feb 19; Vol. 31 (2), pp. 1113-1128. Date of Electronic Publication: 2024 Feb 19.
Autor:
Mendes AS; Medical Oncology Department, Centro Hospitalar Universitário do Porto, Portugal., Romão R; Medical Oncology Department, Centro Hospitalar Universitário do Porto, Portugal., Febra J; Medical Oncology Department, Centro Hospitalar Universitário do Porto, Portugal., Azevedo SX; Medical Oncology Department, Centro Hospitalar Universitário do Porto, Portugal., Fidalgo P; Medical Oncology Department, Centro Hospitalar Universitário do Porto, Portugal., Araújo A; Medical Oncology Department, Centro Hospitalar Universitário do Porto, Portugal.; Oncology Research Unit, UMIB-Unit for Multidisciplinary Research in Biomedicine, ICBAS - School of Medicine and Biomedical Sciences, Universidade do Porto.
Publikováno v:
Thoracic cancer [Thorac Cancer] 2023 Feb; Vol. 14 (5), pp. 437-441. Date of Electronic Publication: 2022 Dec 20.
Autor:
Romão R; Medical Oncology Department, Centro Hospitalar Universitário do Porto, 4099-001 Porto, Portugal., Mendes AS; Medical Oncology Department, Centro Hospitalar Universitário do Porto, 4099-001 Porto, Portugal., Ranchor R; Medical Oncology Department, Centro Hospitalar Universitário do Porto, 4099-001 Porto, Portugal., Ramos MJ; Medical Oncology Department, Centro Hospitalar Universitário do Porto, 4099-001 Porto, Portugal., Coelho J; Medical Oncology Department, Centro Hospitalar Universitário do Porto, 4099-001 Porto, Portugal., Pichel RC; Medical Oncology Department, Centro Hospitalar Universitário do Porto, 4099-001 Porto, Portugal., Azevedo SX; Medical Oncology Department, Centro Hospitalar Universitário do Porto, 4099-001 Porto, Portugal., Fidalgo P; Medical Oncology Department, Centro Hospitalar Universitário do Porto, 4099-001 Porto, Portugal., Araújo A; Medical Oncology Department, Centro Hospitalar Universitário do Porto, 4099-001 Porto, Portugal.; Oncology Research Unit, UMIB-Unit for Multidisciplinary Research in Biomedicine, ICBAS-School of Medicine and Biomedical Sciences, Universidade do Porto, 4050-346 Porto, Portugal.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Jan 31; Vol. 15 (3). Date of Electronic Publication: 2023 Jan 31.
Autor:
Carotenuto P; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.; TIGEM - Telethon Institute of Genetics and Medicine, Naples, Italy., Amato F; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Lampis A; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Rae C; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Hedayat S; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Previdi MC; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Zito D; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Raj M; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Guzzardo V; Department of Medicine, University of Padua, Padua, Italy., Sclafani F; The Royal Marsden NHS Trust, London and Surrey, London, UK., Lanese A; The Royal Marsden NHS Trust, London and Surrey, London, UK., Parisi C; The Royal Marsden NHS Trust, London and Surrey, London, UK., Vicentini C; ARC-Net Research Centre and Department of Diagnostics and Public Health, Section of Pathology, , University of Verona, Verona, Italy., Said-Huntingford I; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Hahne JC; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Hallsworth A; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Kirkin V; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Young K; The Royal Marsden NHS Trust, London and Surrey, London, UK., Begum R; The Royal Marsden NHS Trust, London and Surrey, London, UK., Wotherspoon A; The Royal Marsden NHS Trust, London and Surrey, London, UK., Kouvelakis K; The Royal Marsden NHS Trust, London and Surrey, London, UK., Azevedo SX; The Royal Marsden NHS Trust, London and Surrey, London, UK., Michalarea V; The Royal Marsden NHS Trust, London and Surrey, London, UK., Upstill-Goddard R; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Rao S; The Royal Marsden NHS Trust, London and Surrey, London, UK., Watkins D; The Royal Marsden NHS Trust, London and Surrey, London, UK., Starling N; The Royal Marsden NHS Trust, London and Surrey, London, UK., Sadanandam A; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Chang DK; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK., Biankin AV; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK.; South Western Sydney Clinical School, Faculty of Medicine, University of NSW, Sydney, NSW, Australia., Jamieson NB; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK., Scarpa A; ARC-Net Research Centre and Department of Diagnostics and Public Health, Section of Pathology, , University of Verona, Verona, Italy., Cunningham D; The Royal Marsden NHS Trust, London and Surrey, London, UK., Chau I; The Royal Marsden NHS Trust, London and Surrey, London, UK., Workman P; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Fassan M; Department of Medicine, University of Padua, Padua, Italy.; Veneto Institute of Oncology (IOV-IRCCS), Padua, Italy., Valeri N; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Trust, London and Surrey, London, UK., Braconi C; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK. chiara.braconi@glasgow.ac.uk.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. chiara.braconi@glasgow.ac.uk.; The Royal Marsden NHS Trust, London and Surrey, London, UK. chiara.braconi@glasgow.ac.uk.; Beatson West of Scotland Cancer Centre, Glasgow, UK. chiara.braconi@glasgow.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2021 Nov 18; Vol. 12 (1), pp. 6738. Date of Electronic Publication: 2021 Nov 18.